Curaleaf Holdings Revenue 2019-2024 | CURLF
Curaleaf Holdings revenue from 2019 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| Curaleaf Holdings Annual Revenue (Millions of US $) |
|
|---|---|
| 2023 | $1,347 |
| 2022 | $1,275 |
| 2021 | $1,196 |
| 2020 | $627 |
| 2019 | $221 |
| 2018 | $77 |
| Curaleaf Holdings Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2024-06-30 | $342 |
| 2024-03-31 | $339 |
| 2023-12-31 | $345 |
| 2023-09-30 | $333 |
| 2023-06-30 | $336 |
| 2023-03-31 | $333 |
| 2022-12-31 | $327 |
| 2022-09-30 | $326 |
| 2022-06-30 | $327 |
| 2022-03-31 | $296 |
| 2021-12-31 | $309 |
| 2021-09-30 | $316 |
| 2021-06-30 | $311 |
| 2021-03-31 | $260 |
| 2020-12-31 | $230 |
| 2020-09-30 | $182 |
| 2020-06-30 | $117 |
| 2020-03-31 | $96 |
| 2019-12-31 | $75 |
| 2019-09-30 | $62 |
| 2019-06-30 | $48 |
| 2019-03-31 | $35 |
| 2018-12-31 | $32 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.465B | $1.347B |
| Curaleaf Holdings Inc. operates as a holding company, through its subsidiaries, engages in the production and distribution of cannabis products. Curaleaf Holdings serves dispensary and cultivation sites principally in North America. Curaleaf Holdings Inc. is based in Wakefield, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $199.983B | 25.51 |
| Stryker (SYK) | United States | $140.985B | 31.77 |
| Boston Scientific (BSX) | United States | $128.046B | 36.81 |
| Medtronic (MDT) | Ireland | $113.011B | 16.82 |
| EssilorLuxottica (ESLOY) | France | $112.747B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.300B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.456B | 28.24 |
| GE HealthCare Technologies (GEHC) | United States | $40.356B | 20.93 |
| ResMed (RMD) | United States | $36.485B | 29.98 |
| Terumo (TRUMY) | Japan | $30.261B | 42.74 |
| Koninklijke Philips (PHG) | Netherlands | $25.895B | 19.82 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.637B | 13.78 |
| Baxter (BAX) | United States | $18.387B | 12.47 |
| Insulet (PODD) | United States | $17.177B | 68.43 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.799B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $10.439B | 35.48 |
| BellRing Brands (BRBR) | United States | $8.904B | 37.65 |
| Demant (WILYY) | Denmark | $8.351B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.140B | 14.27 |
| Haemonetics (HAE) | United States | $4.428B | 21.21 |
| ICU Medical (ICUI) | United States | $4.361B | 41.62 |
| TG Therapeutics (TGTX) | United States | $4.320B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.969B | 19.68 |
| Envista Holdings (NVST) | United States | $3.683B | 27.44 |
| Perrigo (PRGO) | Ireland | $3.674B | 10.81 |
| Neogen (NEOG) | United States | $3.420B | 39.45 |
| Agios Pharmaceuticals (AGIO) | United States | $3.141B | 0.00 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.930B | 18.79 |
| QuidelOrtho (QDEL) | United States | $2.612B | 16.82 |
| LeMaitre Vascular (LMAT) | United States | $2.271B | 55.23 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.978B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.958B | 34.26 |
| Warby Parker (WRBY) | United States | $1.944B | 0.00 |
| AtriCure (ATRC) | United States | $1.821B | 0.00 |
| InMode (INMD) | Israel | $1.615B | 9.71 |
| AdaptHealth (AHCO) | United States | $1.322B | 9.45 |
| BioLife Solutions (BLFS) | United States | $1.206B | 0.00 |
| CeriBell (CBLL) | United States | $0.985B | 0.00 |
| Owens & Minor (OMI) | United States | $0.984B | 7.69 |
| Phibro Animal Health (PAHC) | United States | $0.952B | 16.79 |
| National Vision Holdings (EYE) | United States | $0.916B | 30.60 |
| Evolus (EOLS) | United States | $0.905B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.856B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.728B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.625B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.584B | 17.62 |
| Quanterix (QTRX) | United States | $0.579B | 0.00 |
| Surmodics (SRDX) | United States | $0.548B | 0.00 |
| Valneva SE (VALN) | France | $0.445B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.427B | 0.00 |
| ZimVie (ZIMV) | United States | $0.396B | 33.40 |
| Viemed Healthcare (VMD) | United States | $0.350B | 33.33 |
| Cerus (CERS) | United States | $0.327B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.316B | 21.20 |
| Biote (BTMD) | United States | $0.306B | 14.12 |
| Jin Medical (ZJYL) | China | $0.303B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.297B | 0.00 |
| Zynex (ZYXI) | United States | $0.281B | 58.87 |
| MacroGenics (MGNX) | United States | $0.280B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.279B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.265B | 0.00 |
| Omeros (OMER) | United States | $0.261B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.234B | 15.74 |
| High Tide (HITI) | Canada | $0.219B | 90.67 |
| Organigram Holdings (OGI) | Canada | $0.179B | 0.00 |
| Brainsway (BWAY) | Israel | $0.176B | 210.80 |
| FitLife Brands (FTLF) | United States | $0.149B | 20.19 |
| Rockwell Medical (RMTI) | United States | $0.130B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.127B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.117B | 0.00 |
| Veru (VERU) | United States | $0.107B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.107B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.097B | 23.80 |
| Fonar (FONR) | United States | $0.096B | 9.89 |
| Zevia PBC (ZVIA) | United States | $0.087B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.086B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.077B | 0.00 |
| Modular Medical (MODD) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.070B | 0.00 |
| Sanuwave Health (SNWVD) | United States | $0.069B | 1.75 |
| Safety Shot (SHOT) | United States | $0.064B | 0.00 |
| MariMed (MRMD) | United States | $0.056B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.049B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.045B | 0.00 |
| Exagen (XGN) | United States | $0.045B | 0.00 |
| Apyx Medical (APYX) | United States | $0.042B | 0.00 |
| ImmuCell (ICCC) | United States | $0.028B | 0.00 |
| Flora Growth (FLGC) | United States | $0.018B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.011B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.007B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Senestech (SNES) | United States | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 17.28 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |